行情

SSKN

SSKN

STRATA Skin
NASDAQ

实时行情|Nasdaq Last Sale

1.420
-0.045
-3.07%
休市 16:00 01/21 EST
开盘
1.510
昨收
1.465
最高
1.510
最低
1.400
成交量
1.76万
成交额
--
52周最高
2.840
52周最低
1.100
市值
4,879.78万
市盈率(TTM)
-20.7602
分时
5日
1月
3月
1年
5年
STRATA Skin Sciences rises 4% on distribution contract in Israel
STRATA Skin Sciences (NASDAQ:SSKN) entered an agreement with JuvenIL, the dermatology and aesthetics portion of Trimaco, to supply STRATA’s XTRAC excimer lasers in Israel. “Following approval to market our products in
Seekingalpha · 4天前
STRATA Skin Sciences Expands Into Israel With Leading Medical Device Distributor
STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that it has
Benzinga · 4天前
STRATA Skin Sciences Expands into Israel with Leading Medical Device Distributor
Enables STRATA to Commercialize and Market its XTRAC Excimer Lasers to an Estimated 300,000 Psoriasis and 160,000 Vitiligo Patients in IsraelHORSHAM, Pa., Jan. 18, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology com...
GlobeNewswire · 4天前
Brief-Strata Skin Sciences 提交与通过出售股东转售多达 358,367 股普通股相关的招股说明书
reuters.com · 01/13 22:04
The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
Here's a roundup of top developments in the biotech space over the last 24 hours:
Benzinga · 01/11 13:20
STRATA Skin Sciences 收购 Theravant 的痤疮治疗设备,预计第四季度销售额将上升
STRATA Skin Sciences Inc (NASDAQ: SSKN) expects 
Benzinga · 01/11 11:43
STRATA Skin Sciences to acquire assets related to Theravant's acne treatment
STRATA Skin Sciences (NASDAQ:SSKN) will acquire assets related to Theravant's TheraClear System, which marks SSKN's expansion into the acne treatment market. STRATA will acquire substantially all assets, owned or controlled by
Seekingalpha · 01/10 21:11
STRATA Skin Sciences Announces Acquisition Of Acne Treatment Device Assets From Theravant Corporation For ~$1M Upfront Payment And Milestone-Based Payments
Substantially broadens STRATA’s opportunity for expansion potential into the estimated $5.5 billion acne care market   Leverages STRATA’s innovative marketing platform, commercial team and
Benzinga · 01/10 21:02
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解SSKN最新的财务预测,通过SSKN每股收益,每股净资产,每股现金流等数据分析STRATA Skin近期的经营情况,然后做出明智的投资选择。
分析师评级

2位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

100.00%强力推荐
0.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测SSKN价格均价为4.300,最高价位4.600,最低价为4.000。
最高4.600
均价4.300
最低4.000
现价1.420
EPS
实际EPS
预期EPS
-0.05-0.03-0.010.02
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
机构持股
总机构数: 37
机构持股: 1,251.51万
持股比例: 36.42%
总股本: 3,436.47万
类型机构数股数
增持
5
3.19万
建仓
3
50.56万
减持
4
5.14万
平仓
1
775
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
先进医疗设备和技术
-2.18%
医疗设备和用品
-1.50%
高管信息
Non-Executive Chairman/Independent Director
Uri Geiger
President/Chief Executive Officer/Director
Robert Moccia
Chief Financial Officer
Christopher Lesovitz
Independent Director
William Humphries
Independent Director
Samuel Navarro
Independent Director
Samuel Rubinstein
Independent Director
Nachum Shamir
Independent Director
Douglas Strang
暂无数据
SSKN 简况
STRATA Skin Sciences, Inc是一家医疗技术公司。该公司从事整形外科业务,开发、商业化和营销用于治疗皮肤病的产品。该公司通过两个分部运营:皮肤科重复手术分部和皮肤科手术设备分部。该公司的产品包括XTRAC和Pharos准分子激光器以及VTRAC灯系统,用于治疗银屑病、白癜风和其他各种皮肤病。该公司的XTRAC准分子激光器提供有针对性的治疗性紫外线B(UVB)光束,用于治疗银屑病、白斑、湿疹、特应性皮炎和白斑病。Pharos是其准分子激光设备,可发射集中的紫外线(UV)光,用作治疗皮肤病的工具。VTRAC是一种紫外线灯系统,用于治疗牛皮癣、白癜风和其他各种皮肤病。

微牛提供STRATA Skin Sciences Inc(NASDAQ-SSKN)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的SSKN股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易SSKN股票基本功能。